Counterpoint: The case for immediate active treatment

Stacy Loeb, William J. Catalona*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Active monitoring strategies recently have received attention as possible treatment options for men with low-risk prostate cancer who have a life expectancy of more than 10 years. However, no current criteria sufficiently predict outcomes for individuals with clinically localized disease and an otherwise long life expectancy who undergo either immediate or delayed treatment, or no treatment. This article describes the available evidence regarding treatment outcomes in men with low-risk prostate cancer and presents the case for immediate active treatment.

Original languageEnglish (US)
Pages (from-to)699-702
Number of pages4
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number7
StatePublished - Aug 2007


  • Active monitoring
  • Immediate treatment
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Counterpoint: The case for immediate active treatment'. Together they form a unique fingerprint.

Cite this